The industry's own research.
112 reports
showing 1–60 of 112
NAIOP Research Foundation report evaluating risks and opportunities in office building conversions to life science, medical, and multifamily uses, based on market data review and developer interviews.
A podcast discussion examining capital allocation trends across residential, life sciences, and data-driven real estate investment strategies.
The San Francisco Bay Area's beleaguered life science market posted positive net absorption and a rebound in venture funding in the second quarter, according to Newmark, even as record vacancy, falling rents and a frozen construction pipeline showed how far recovery remains. The post Bay Area Life Science Market…
Knight Frank examines the capital requirements and investment dynamics supporting UK life sciences innovation beyond real estate considerations.
Institutional investors are increasingly allocating to alternative real estate sectors including data centres, life sciences, cold storage and manufactured housing for portfolio differentiation.
JLL research identifies significant shifts in life sciences laboratory space demand across the Greater Boston market.
Silicon Valley’s industrial and research-and-development markets both firmed in the second quarter of 2026 as artificial intelligence and advanced manufacturing tenants absorbed large blocks, pushed vacancy lower and pulled the region’s commercial real estate fundamentals back toward pre-downturn norms. The…
At the 2026 ULI Carolinas Meeting, leaders from government, life sciences, and professional sports argued that housing, infrastructure, and energy systems—not population growth itself—will determine whether the region can sustain its momentum.
CBRE analyzes life sciences lab and R&D market fundamentals and demand indicators for Q2 2026.
By Kimm Lauterbach, REDI Cincinnati Shaped by its strong German heritage, brewing tradition and historic role as the nation’s pork-processing capital, earning the nickname “Porkopolis,” the Cincinnati region has long been defined by industry, entrepreneurship and innovation. That legacy of reinvention has…
JLL’s Future of Work 2026 survey gathers insights from Corporate Real Estate (CRE) decision-makers worldwide. Responses from Asia Pacific’s life sciences organisations reveal three shifts, drawing on responses from 91 decision-makers across the region: The sector is embracing AI while keeping people at its core The…
Technology labs are becoming critical assets requiring specialized CRE strategies and operational expertise
Technology labs are becoming critical assets requiring specialized CRE strategies and operational expertise
GCC focus
JLLの専門家による世界の不動産市場の予測および地域・国別の展望に対する経済・地政学的トレンドの影響についての見解。
This is a Knight Frank outlook and forecast report published in December 2025 covering Asia-Pacific real estate in 2026, examining the sector within the context of regional structural economic conditions.
JLL examines GCC life sciences clusters and investment opportunities driven by healthcare self-sufficiency mandates, with the pharmaceutical market exceeding $30B and biotech investment topping $12B over five years.
CBRE market analysis of laboratory and life-sciences real estate conditions in Montreal.
An analysis of Spain's strategic positioning and development within the European life sciences real estate market.
The 14th Five-Year Plan supports Hong Kong to develop into an international innovation and technology (I&T) centre. This paper examines some potential opportunities in Northern Metropolis to respond to and capitalise on the national development strategies.
Capital Economics examines life science real estate fundamentals and performance outlook, noting pandemic-driven reinforcement of long-term demand despite recent supply constraints.
Exploration of how the 5th Industrial Revolution and AI adoption are reshaping real estate strategies and asset positioning.
This is a viewpoint-commentary published by Institutional Real Estate, Inc. in April 2026 addressing how demand in Asia Pacific life sciences and research and development real estate can be converted into investment opportunities. The piece covers topics related to capital markets and economic considerations in this property sector.
Analysis of office-to-alternate-use conversion trends, arguing that life sciences properties experienced greater market impact than multifamily adaptive reuse projects.
Market data on life sciences leasing activity in the first half of 2025, showing below-pre-pandemic levels with regional variations in recovery.
This is a market report published by CBRE in April 2025 covering the life sciences sector in Sydney, Australia. The report is part of CBRE's Global Life Sciences Atlas series and provides market intelligence for the Asia-Pacific region focused on the Sydney market.
This is a market report published by CBRE in April 2025 covering the life sciences sector in the San Francisco Bay Area. The report provides analysis of the regional life sciences real estate market with national context.
This is a market report published by CBRE in April 2025 covering the life sciences sector in the Boston-Cambridge area. The report appears to be part of a broader global atlas examining life sciences real estate markets.
This is a market report published by CBRE in April 2025 covering the life sciences sector in the Washington, DC-Baltimore market area.
This is a market report published by CBRE in April 2025 covering the life sciences sector in Melbourne, Australia. The report is part of CBRE's Global Life Sciences Atlas series and focuses on the Asia-Pacific region.
This is a market report published by CBRE in April 2025 covering the life sciences sector in the New York City market. The report is part of CBRE's Global Life Sciences Atlas series and includes geographic focus on New York State and national scope.
This is a market report published by Newmark in the fourth quarter of 2025 providing an overview of the life sciences sector in Boston, Massachusetts.
This is a market report published by Newmark in the first quarter of 2025 covering the life science sector in the San Francisco Bay Area.
Analysis of evolving demand dynamics in Germany's life sciences real estate sector, highlighting increased selectivity and the growing importance of standardized processes, regulatory frameworks, and suitable space availability.
While pharmaceutical companies acquire sponsor-backed biotech companies, corporate real estate teams are becoming more responsible for preserving the value of those deals, according to a new CBRE insight. Even as acquired biotech firms tend to have smaller real estate footprints and leaner workforces, they become…
In the labor market, life sciences hubs continue to rely on talent to drive innovation. According to Cushman & Wakefield’s 2026 Life Sciences Labor Dynamics Across Key U.S. Markets report, labor is also essential for site selection. Report authors Sandy Romero (Head of Office & Alternatives) and Maggie Tillotson…
Colliers analysis of Peninsula R&D market conditions showing early stabilization signals and life sciences activity recovery.
Colliers analysis of capitalization rate trends across Asia-Pacific markets, noting compressed cap rates in sectors with low vacancy and strong space demand, alongside gradually declining interest rates.
Cushman & Wakefield's forward-looking analysis of real estate market trends, drivers, and forecasts across the Asia-Pacific region.
The Greater Boston lab market posted its first quarter of positive net absorption in nearly a year for the second quarter of 2026, representing what CBRE called “a tentative sign of stabilization amid persistent headwinds.” Total market availability edged up 10 basis points from Q1 and 60 bps from Q2 2025 to 32.8%,…
The life sciences real estate sector in Greater Boston still has a deep hole to dig out of, with millions of square feet of lab buildings sitting vacant, but a new report shines a positive light on the future of the market’s demand.
Moody's CRE Analytics publishes performance metrics for the technology sector real estate market in Q4 2024.
CBRE publishes quarterly figures on the Bay Area life sciences real estate market.
Market intelligence covering UK life science real estate trends, occupier demand, investment activity, and asset valuations.
CBRE examines hidden real estate considerations and cost factors that arise during mergers and acquisitions in the life sciences sector.
Capital Economics examines how alternative real estate sectors are positioned to benefit from structural trends and lower cyclical sensitivity in a weak economic growth environment.
Capital Economics shares insights and outlook perspectives on alternative real estate assets drawn from client roundtable discussions.
Research evaluating risks and opportunities in converting office buildings to life science, medical, and multifamily uses, based on market data and interviews with developers and architects.
Research examining how REITs invested in tech-related property sectors can reduce portfolio volatility and provide exposure to 21st century real estate.
An examination of key success factors in life sciences real estate development and the outlook for capital deployment in the biotech sector.
Carter Jonas' biannual update on life sciences sector outlook across UK key markets including Oxford, Cambridge, and London.
CBRE examines the intersection of high-performance computing, life sciences research, and artificial intelligence as drivers of real estate demand and innovation infrastructure.
This is a sector spotlight report published by CBRE on June 24, 2026, examining six talent trends within the life sciences industry and their connection to property demand across national markets.
1. The market is correcting, not collapsing Speaker credit: Jeff Myers, Nader Elrashidy The life sciences market has clearly moved out of its peak-growth phase, but that does not mean the sector is broken. The better read is that the market is recalibrating after several years of rapid expansion, heavy investment,…
Raleigh-Durham life sciences vacancy peaked in late 2025 and improved through Q1 2026 as spec space was absorbed.
The document is a navigation and index page for Cushman & Wakefield's Raleigh MarketBeats reports covering Q1 2026 across office, industrial, life sciences, and multifamily property sectors. It provides summary statistics including office vacancy at 22.3% (up 10 basis points quarter-over-quarter), industrial vacancy at 9.0% (up 90 basis points), life sciences vacancy at 27.6% (down 120 basis points), and notes that the Raleigh-Durham multifamily market has delivered over 33,000 units since 2023.
This is a data report published by CBRE on March 31, 2026 presenting Q1 2026 research and development figures for Silicon Valley, covering the office and life-sciences sectors across San Jose, San Francisco, California, and national markets.
This document is a landing page for Cushman & Wakefield's Silicon Valley MarketBeat reports covering Q1 2026 across office, industrial, retail, and R&D property sectors. The page presents first-quarter 2026 vacancy rates: office at 18.8%, industrial at 6.4%, retail at 4.9%, and R&D at 13.0%, along with links to detailed reports on each sector and related Bay Area life sciences and investment market data.
This is a market research report published by Colliers in Q4 2025 covering the research and development real estate sector in the San Jose-Silicon Valley area. The report addresses office and life-sciences sectors and includes geographic coverage of San Jose, California, the broader San Francisco region, and national context.
This is a data-figures report published by CBRE on March 31, 2026, presenting first-quarter 2026 figures for the life sciences sector in Philadelphia, Pennsylvania.